SCHEMBL16629231

SCHEMBL16629231

Cn1nc(NC(=O)OC(C)(C)C)cc1C(N)=O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IRAK4 Q9NWZ3 1/20 0.40
GSK3B P49841 1/20 0.40
DYRK1A Q13627 1/20 0.40
MAPK14 Q16539 1/20 0.40
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
JAK2 O60674 1/20 0.38
PTGER1 P34995 2/20 0.37
KDM4E B2RXH2 3/20 0.36
CYP2C9 P11712 1/20 0.36
BRD9 Q9H8M2 1/20 0.36
GRN P28799 1/20 0.36
SORT1 Q99523 1/20 0.36
ALDH1A1 P00352 2/20 0.35
LMNA P02545 2/20 0.35
GAA P10253 1/20 0.35
MAP4K4 O95819 1/20 0.34
SCN9A Q15858 1/20 0.34
STING1 Q86WV6 2/20 0.33
CYP17A1 P05093 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16629255 0.87 KDM4E (0.50) IRAK4GSK3BDYRK1AMAPK14CA1
SCHEMBL31714479 0.84 GSK3B (0.39) IRAK4GSK3BDYRK1AMAPK14CA1
SCHEMBL12050053 0.81 ALDH1A1 (0.55) IRAK4GSK3BDYRK1AMAPK14CA1
SCHEMBL22952388 0.79 MAPK14 (0.44) IRAK4GSK3BDYRK1AMAPK14CA1
SCHEMBL28690858 0.79 MAPK14 (0.41) IRAK4GSK3BDYRK1AMAPK14CA1
SCHEMBL24077319 0.77 GSK3B (0.40) GSK3BDYRK1AMAPK14CA1CA2
SCHEMBL20885944 0.77 MAPK14 (0.42) IRAK4GSK3BDYRK1AMAPK14CA1
SCHEMBL20885898 0.77 MAPK14 (0.42) IRAK4GSK3BDYRK1AMAPK14CA1
SCHEMBL22445343 0.77 GSK3B (0.40) IRAK4GSK3BDYRK1AMAPK14CA1
SCHEMBL26293644 0.77 NPC1 (0.48) GSK3BDYRK1AMAPK14CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015050989-A2 MACROCYCLIC COMPOUNDS FOR THE TREATMENT OF PROLIFERATIVE DISEASES CS THERAPEUTICS INC. (US) 2015-04-09 WO disclosed